"The IBA offer is the best option available to iSoft and we continue to believe that this is the case." iSoft is under pressure to seal a deal after securing short-term banking arrangements last August. These are due to expire in November and will generate progressively higher levels of interest payments until then. Ovum analyst Phil Codling said that CSC's objections to the deal were likely to focus on the impact on iSoft's software development for the NHS IT programme. He said: "CSC is paid when it hits milestones on delivering within NPfIT.